Callan JMB Inc. Common Stock (CJMB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Callan JMB Inc. Common Stock (CJMB) has a cash flow conversion efficiency ratio of -0.581x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-396.06K) by net assets ($681.86K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Callan JMB Inc. Common Stock market capitalisation for the company's overall valuation and market capitalisation.
Callan JMB Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how Callan JMB Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Callan JMB Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Callan JMB Inc. Common Stock ranked by their cash flow conversion efficiency. Explore CJMB cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Korea Plasma Technology U Co.Ltd
KQ:054410
|
0.004x |
|
Wegmans Holdings Berhad
KLSE:0197
|
-0.017x |
|
Nafpaktos Textile Industry S.A
AT:NAYP
|
0.024x |
|
InnoTherapy Inc
KQ:246960
|
-0.004x |
|
Mico BioMed Co. Ltd.
KQ:214610
|
-0.315x |
|
Serica Energy PLC
LSE:SQZ
|
0.080x |
|
Arita Prima Indonesia Tbk
JK:APII
|
0.022x |
|
Embelton Ltd
AU:EMB
|
0.033x |
Annual Cash Flow Conversion Efficiency for Callan JMB Inc. Common Stock (2022–2025)
The table below shows the annual cash flow conversion efficiency of Callan JMB Inc. Common Stock from 2022 to 2025. View CJMB live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.33 Million | $-4.55 Million | -1.953x | -1246.96% |
| 2024-12-31 | $3.17 Million | $540.35K | 0.170x | -78.59% |
| 2023-12-31 | $8.80 Million | $7.00 Million | 0.795x | +19.02% |
| 2022-12-31 | $14.01 Million | $9.36 Million | 0.668x | -- |
About Callan JMB Inc. Common Stock
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryo… Read more